Mindfulness Based Smoking Cessation Program
Feasibility, Acceptability and Effectiveness of Modified Mindfulness Based Stress Reduction (MBSR) for Smoking Cessation in Cancer Patients
2 other identifiers
interventional
18
1 country
1
Brief Summary
This is a study designed to mindfulness based stress reduction (MBSR) training program to assess feasibility and acceptability of the intervention. Participants will participate in a 9-week training program and complete pre-and post-questionnaires. Participants will have the option of participating in a follow-up focus group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
June 10, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedJanuary 6, 2020
January 1, 2020
1.7 years
June 1, 2016
January 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants engaged in smoking cessation counseling
Participants will complete a weekly intake form and a telephone based questionnaire at 3 months to assess engagement in evidence based smoking cessation counseling by completion of one of the following: (a) at least 1 visit with Boston Medical Center pulmonary smoking cessation program for individual quit plan, or (b) at least 1 telephone based Quitworks counseling session, or (c) \>1 PCP or Oncology visit in which smoking cessation treatment is discussed.
3 months
Secondary Outcomes (4)
Number of patients with reduced stress assessed using validated Perceived Stress Scale (PSS)
3 months
Number of patients reporting readiness to quit smoking based on the Transtheoretical Model and Stages of Change
3 months
Number of participants identifying a smoking quit date
3 months
Number of participants reporting 7 day smoking abstinence from cigarettes
3 months
Study Arms (1)
Smoking Cessation Training Program
EXPERIMENTALParticipants will take part in a 9-week Smoking Cessation Program class curriculum consisting of weekly 2.5 hour classes and complete pre and post questionnaires
Interventions
Participants will take part in a 9-week Smoking Cessation Program
Eligibility Criteria
You may qualify if:
- age 18 or older
- smoked cigarettes in the past week
- cancer diagnosis more than 6 months
- have a scheduled visit in the oncology clinic with an oncologist or mid-level provider
- telephone access
- English speaking for screening/consenting purposes
- able and willing to participate in the study protocol and provide informed consent
You may not qualify if:
- cancer prognosis less than 6 months
- planning to move out of the area within 6 months
- actively using evidence-based smoking cessation treatment during screening
- pregnant women and women planning on becoming pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marjory Charlot, MD
Boston Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2016
First Posted
June 10, 2016
Study Start
July 1, 2016
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
January 6, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be included in any publications